These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8913922)

  • 21. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Heart transplantation 1985-1995: 10 years experience at the "Angelo De Gasperis" center. Improvement of results by progress in operative criteria].
    Colombo T; Borrello B; Lanfranconi M; Pomé G; Quaini E; Russo C; Vitali E; Grassi M; Frigerio M; Gronda E; Mangiavacchi M; Merli M; Pellegrini A
    G Ital Cardiol; 1997 Jan; 27(1):3-18. PubMed ID: 9244710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.
    Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P;
    Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticosteroid weaning late after heart transplantation: relation to HLA-DR mismatching and long-term metabolic benefits.
    Kobashigawa JA; Stevenson LW; Brownfield ED; Gleeson MP; Moriguchi JD; Kawata N; Minkley R; Drinkwater DC; Laks H
    J Heart Lung Transplant; 1995; 14(5):963-7. PubMed ID: 8800734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.
    Keogh A; Macdonald P; Harvison A; Richens D; Mundy J; Spratt P
    J Heart Lung Transplant; 1992; 11(2 Pt 2):421-7. PubMed ID: 1571340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid-free immunosuppression in kidney transplant recipients: the University of Minnesota experience.
    Humar A; Dunn T; Kandaswamy R; Payne WD; Sutherland DE; Matas AJ
    Clin Transpl; 2007; ():43-50. PubMed ID: 18637457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation.
    Karamlou T; Hirsch J; Welke K; Ohye RG; Bove EL; Devaney EJ; Gajarski RJ
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):161-8. PubMed ID: 20434179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation.
    Olivari MT; Kubo SH; Braunlin EA; Bolman RM; Ring WS
    Circulation; 1990 Nov; 82(5 Suppl):IV276-80. PubMed ID: 2225416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients.
    Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR
    J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation.
    Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G
    J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D
    J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry.
    Brann WM; Bennett LE; Keck BM; Hosenpud JD
    J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience.
    Pritzker MR; Lake KD; Reutzel TJ; Hoffman FM; Jorgensen CR; Pederson W; Emery RW
    J Heart Lung Transplant; 1992; 11(2 Pt 2):415-20. PubMed ID: 1571339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic determinants of six-month morbidity and mortality in heart transplant recipients. The Italian Study Group on Infection in Heart Transplantation.
    De Maria R; Minoli L; Parolini M; Gavazzeni G; Gentile M; Grossi P; Livi U; Parisi F; Utili R
    J Heart Lung Transplant; 1996 Feb; 15(2):124-35. PubMed ID: 8672515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with cardiac retransplantation.
    Michler RE; McLaughlin MJ; Chen JM; Geimen R; Schenkel F; Smith CR; Barr ML; Rose EA
    J Thorac Cardiovasc Surg; 1993 Oct; 106(4):622-9; discussion 629-31. PubMed ID: 8412255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database.
    Weiss ES; Nwakanma LU; Patel ND; Yuh DD
    J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.